首页> 外文期刊>Veterinary World >5. The immunomodulatory effect of green tea ( Camellia sinensis ) leaves extract on immunocompromised Wistar rats infected by Candida albicans
【24h】

5. The immunomodulatory effect of green tea ( Camellia sinensis ) leaves extract on immunocompromised Wistar rats infected by Candida albicans

机译:5.绿茶(茶花)叶提取物对白色念珠菌感染的免疫功能低下的Wistar大鼠的免疫调节作用

获取原文
           

摘要

Background and Aim: The immunocompromised condition is considered a defect in the immune system. This condition tends to increase the risk of oral candidiasis, due to the inability of the immune system to eliminate the adhesion of Candida albicans and leads to systemic candidiasis with a mortality rate of 60%. Green tea (Camellia sinensis) contains potential antioxidant and immunomodulatory which acts as anticancer, antifungal, and antivirus agent. The aim of this study was to invent herbal-based medicine, which acts as an immunomodulator and antifungal agent to treat fungal infection in immunocompromised patients. Materials and Methods: Thirty-five immunocompromised Wistar rats induced with C. albicans were divided into 7 groups (n=5): Control group (C+); treated for 4 days with green tea extract 1.25% (GT 4), epigallocatechin gallate (EGCG) 1% (EGCG 4), EGC 1% (EGC 4); and treated for 7 days with green tea extract 1.25% (GT 7), EGCG 1% (EGCG 7), and EGC 1% (EGC 7). Tongue tissue was collected and analyzed with immunohistochemistry staining using monoclonal antibody; interleukin (IL)-17A, IL-8, and human beta-defensin 2 (HBD)-2. Data were analyzed using analysis of variance test and Tukey honest significant differences test. Results: The expression of IL-17A, IL-8, and HBD-2 was significantly increased (p=0.000) after green tea extract administration in 7 days, whereas in 7 days, the expression of IL-8, IL-17A, and HBD-2 after EGCG and EGC administration did not give a significant result (p>0.005). Conclusion: Within the limits of this study, green tea extract has the ability as an immunomodulatory agent in an immunocompromised patient infected by C. albicans through expression augmentation of IL-8, IL-17A, and HBD-2 compared to EGCG and EGC.
机译:背景与目的:免疫功能低下的疾病被认为是免疫系统的缺陷。由于免疫系统无法消除白色念珠菌的粘附,这种情况往往会增加口腔念珠菌病的风险,并导致全身性念珠菌病,死亡率为60%。绿茶(Camellia sinensis)含有潜在的抗氧化剂和免疫调节剂,可作为抗癌剂,抗真菌剂和抗病毒剂。这项研究的目的是发明基于草药的药物,该药物可作为免疫调节剂和抗真菌剂来治疗免疫功能低下患者的真菌感染。材料与方法:35只白色念珠菌诱导免疫功能低下的Wistar大鼠分为7组(n = 5):对照组(C +);对照组(C +)。用绿茶提取物1.25%(GT 4),表没食子儿茶素没食子酸酯(EGCG)1%(EGCG 4),EGC 1%(EGC 4)处理4天;并用绿茶提取物1.25%(GT 7),EGCG 1%(EGCG 7)和EGC 1%(EGC 7)处理7天。收集舌组织,并使用单克隆抗体进行免疫组织化学染色分析;白介素(IL)-17A,IL-8和人β-防御素2(HBD)-2。使用方差分析和Tukey诚实显着差异检验分析数据。结果:施用绿茶提取物后7天,IL-17A,IL-8和HBD-2的表达显着增加(p = 0.000),而在7天后,IL-8,IL-17A, EGCG和EGC给药后HBD-2和HBD-2的结果无统计学意义(p> 0.005)。结论:在这项研究的范围内,与EGCG和EGC相比,绿茶提取物能够通过IL-8,IL-17A和HBD-2的表达增强,在被白色念珠菌感染的免疫功能低下患者中作为免疫调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号